Catalyst Wire Dossier Catalyst Wire Dossier

Uproleselan

uproleselan
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for Uproleselan, covering 2024-08-19 to 2026-02-23. Get the full timeline:

Most recent: Clinical Trial Update: Uproleselan, Azacitidine, and Venetoclax for the Treatment of Treatment Naive Acute Myeloid Leukemia [Phase 1]

See pricing